Enrichment analysis of genes dysregulated following Oprelvekin treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00014115
TitleEnrichment analysis of genes dysregulated following Oprelvekin treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Oprelvekin treated cells and untreated control cells in the lymphocytes cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3087966
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorgaribr01
CREEDS IDdrug:3297
Cell Typelymphocytes
Drug NameOprelvekin
DrugBank IDDB00038
Organismhuman
Characteristic Direction parameters
Control SamplesGSM217766, GSM217767, GSM217768, GSM217771, GSM217772, GSM217773
Perturbed SamplesGSM217776, GSM217777, GSM217778, GSM217784, GSM217785, GSM217786
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE8762
Gene Expression Omnibus
Moderate stage Huntington's disease lymphocytes
21
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.